Kaempferol is a common plant flavonol. The strongest human signal sits in long-term eating patterns, not high-dose oral supplements. Higher dietary flavonol intake is linked to lower stroke, cardiovascular, and Alzheimer dementia risk. Short clinical work supports near-term safety at modest doses. Evidence favors flavonol-rich plants over aggressive isolated capsules; drug-interaction questions remain. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Blood pressure (office or home) | ~110–120 / <80 mmHg (individualized) | Tracks vascular response if flavonols affect tone |
| hs-CRP | <1.0 mg/L | General inflammatory tone |
| Fasting glucose / HbA1c | Glucose 70–90 mg/dL; HbA1c <5.3% | Metabolic context for polyphenol use |
| ALT / AST | Within laboratory reference range | Baseline if polypharmacy or high-dose botanicals |
| Complete blood count | Age/sex reference | Safety net with any new supplement |
| Serum ferritin | ~40–100 ng/mL (context-dependent) | Iron stores if high polyphenol intake |
| Lipid panel (ApoB preferred) | ApoB as low as practical for risk tier | CVD risk context of flavonol literature |
Cadence: If supplementing: safety labs at ~4 weeks, then every 6–12 months or with regimen changes; home blood pressure weekly during the first month. Optional for food-only strategies in healthy adults.